具有致病性KCNQ2变异的人类iPSC衍生的谷氨酸性神经元表现出过度活跃的爆发表型
Maria Sundberg1, Carole Shum2, Erika M Norabuena3
1Department of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Neurobiology of disease
|September 27, 2025
概括
致病性KCNQ2基因变异会导致严重的神经疾病. 来自患者的神经元显示出明显的细胞和网络功能障碍,为向药物查和治疗开发提供了新的途径.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 干细胞生物学 干细胞生物学
背景情况:
- KCNQ2基因的致病变体与严重的神经疾病有关,包括新生儿发作和脑病.
- 驱动这些KCNQ2相关的神经现象型的精确分子机制尚未完全理解.
- 针对患者的神经元模型对于研究这些变体和开发治疗方法至关重要.
研究的目的:
- 产生和表征患者特异性诱导多能干细胞 (iPSC) 衍生神经元,其中包含不同的KCNQ2致病变体.
- 研究这些KCNQ2变异对神经元发育和网络活动的功能影响.
- 建立适用于药物查的KCNQ2相关疾病的疾病模型.
主要方法:
- 从具有三个不同的KCNQ2致病变体的个体的纤维细胞生成患者特异性的iPSCs.
- 利用CRISPR-Cas9基因编辑来创建同位素控制线.
- 在功能性和分子分析中将差异化的iPSCs转化为谷氨酸性神经元.
- 使用高密度微电极阵列用于网络电生理学.
主要成果:
- 患者衍生的神经元表现出改变的神经元外生和转录形状,丰富了突触和细胞粘附通路.
- 这三种KCNQ2变种线都显示神经元爆发持续时间增加.
- 特定的变异导致了网络连接和突触标记密度的增加.
- 一种变种 (G256W) 显示出过度刺激的网络,这些网络通过治疗 retigabine 得到拯救.
结论:
- 患者特异的iPSC衍生神经元准确地模拟KCNQ2相关的神经现象.
- 不同的KCNQ2变异导致独特的细胞和网络功能障碍.
- 这些模型为确定KCNQ2通道病变的治疗干预提供了宝贵的平台.
更多相关视频
06:54Quantifying Spontaneous Ca2+ Fluxes and their Downstream Effects in Primary Mouse Midbrain Neurons
Published on: September 9, 2020
6.7K
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
1.4K
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Excitatory and Inhibitory Effects of Neurotransmitters
When an action potential reaches the presynaptic axon terminal, it releases neurotransmitters from the neuron into the synaptic cleft at a chemical synapse. The released neurotransmitter can be excitatory or inhibitory. The critical criteria commonly used to determine whether a molecule is a neurotransmitter at a chemical synapse are the molecule's presence in the presynaptic neuron. Second, its release is in response to strong presynaptic depolarization. And lastly, the presence of specific...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
